Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
Boehringer Ingelheim
National Cancer Institute (NCI)
AstraZeneca
Gruppo Oncologico del Nord-Ovest
M.D. Anderson Cancer Center
Gruppo Oncologico del Nord-Ovest
Daiichi Sankyo
GI Innovation, Inc.
Silverback Therapeutics
Daiichi Sankyo